These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34117809)
1. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer. Chabrol E; Fagnen C; Landron S; Marcheteau E; Stojko J; Guenin SP; Antoine M; Fould B; Ferry G; Boutin JA; Vénien-Bryan C Protein Sci; 2021 Sep; 30(9):1946-1957. PubMed ID: 34117809 [TBL] [Abstract][Full Text] [Related]
2. In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody. Richard G; Meyers AJ; McLean MD; Arbabi-Ghahroudi M; MacKenzie R; Hall JC PLoS One; 2013; 8(7):e69495. PubMed ID: 23894495 [TBL] [Abstract][Full Text] [Related]
3. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product. Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677 [TBL] [Abstract][Full Text] [Related]
4. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity. Ji X; Lu W; Zhou H; Han D; Yang L; Wu H; Li J; Liu H; Zhang J; Cao P; Zhang S Appl Microbiol Biotechnol; 2013 Oct; 97(19):8547-58. PubMed ID: 23324801 [TBL] [Abstract][Full Text] [Related]
5. Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds. De Buck S; Nolf J; De Meyer T; Virdi V; De Wilde K; Van Lerberge E; Van Droogenbroeck B; Depicker A Plant Biotechnol J; 2013 Oct; 11(8):1006-16. PubMed ID: 23915060 [TBL] [Abstract][Full Text] [Related]
6. Fcab-HER2 Interaction: a Ménage à Trois. Lessons from X-Ray and Solution Studies. Lobner E; Humm AS; Göritzer K; Mlynek G; Puchinger MG; Hasenhindl C; Rüker F; Traxlmayr MW; Djinović-Carugo K; Obinger C Structure; 2017 Jun; 25(6):878-889.e5. PubMed ID: 28528777 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the Fc-III-4C-based recombinant protein expression system by using carbonic anhydrase as the model protein. Gong Y; Yi M; Zhang L; Feng S; Deng H Protein Expr Purif; 2021 Jan; 177():105761. PubMed ID: 32956801 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK. Vaidyanathan G; Jestin E; Olafsen T; Wu AM; Zalutsky MR Nucl Med Biol; 2009 Aug; 36(6):671-80. PubMed ID: 19647173 [TBL] [Abstract][Full Text] [Related]
11. Introduction to heavy chain antibodies and derived Nanobodies. Vincke C; Muyldermans S Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243 [TBL] [Abstract][Full Text] [Related]
12. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products. Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J; Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438 [TBL] [Abstract][Full Text] [Related]
13. Construction and expression of an anti-VEGFR2 Nanobody-Fc fusionbody in NS0 host cell. Qasemi M; Behdani M; Shokrgozar MA; Molla-Kazemiha V; Mohseni-Kuchesfahani H; Habibi-Anbouhi M Protein Expr Purif; 2016 Jul; 123():19-25. PubMed ID: 26996993 [TBL] [Abstract][Full Text] [Related]
14. Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors. Blundell PA; Le NPL; Allen J; Watanabe Y; Pleass RJ J Biol Chem; 2017 Aug; 292(31):12994-13007. PubMed ID: 28620050 [TBL] [Abstract][Full Text] [Related]
15. A rapid and simple pipeline for synthesis of mRNA-ribosome-V(H)H complexes used in single-domain antibody ribosome display. Bencurova E; Pulzova L; Flachbartova Z; Bhide M Mol Biosyst; 2015 Jun; 11(6):1515-24. PubMed ID: 25902394 [TBL] [Abstract][Full Text] [Related]
16. Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties. Wozniak-Knopp G; Bartl S; Bauer A; Mostageer M; Woisetschläger M; Antes B; Ettl K; Kainer M; Weberhofer G; Wiederkum S; Himmler G; Mudde GC; Rüker F Protein Eng Des Sel; 2010 Apr; 23(4):289-97. PubMed ID: 20150180 [TBL] [Abstract][Full Text] [Related]
17. Functional mutations in and characterization of VHH against Helicobacter pylori urease. Hoseinpoor R; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Shahi B Appl Biochem Biotechnol; 2014 Mar; 172(6):3079-91. PubMed ID: 24492955 [TBL] [Abstract][Full Text] [Related]
18. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484 [TBL] [Abstract][Full Text] [Related]
19. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries. Ferrari D; Garrapa V; Locatelli M; Bolchi A Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928 [TBL] [Abstract][Full Text] [Related]
20. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies]. Xia X; M M; Zhai T; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]